Report: Women’s Health Diagnostic Tests from Piribo.com

1.0 Overview
1.1 Statement of Report
1.2 Scope of this Report
1.3 Methodology
1.4 Executive Summary
2.0 Introduction - Sector Overview
2.1 Global Diagnostic Products Industry
3.0 Women's Health Testing Market Analysis in Size, Growth and Share
3.1 Global Women's Health Testing Markets
- 3.1.1 Market Drivers in the Women's Health Diagnostics Testing Sector
  - 3.1.1.2 Market Segments for Women's Health Testing
  - 3.1.1.3 Key Players in the Women's Health Diagnostics Testing Segment
  - 3.1.1.4 Women's Health Testing Sector Analysis
3.2 U.S. Women's Health Testing Market
- 3.2.1 Market Overview
- 3.2.2 Diagnostic Test Categories
3.3 Description of the European Women's Health Diagnostic Test Market
- 3.3.1 German Women's Care Diagnostic Market
- 3.3.2 U.K. Women's Care Testing Diagnostic Market
  - 3.3.2.1 U.K. Market Statistics
  - 3.3.2.2 U.K. Competitive Analysis
  - 3.3.2.3 U.K. Market Access
- 3.3.3 French Women's Care Diagnostic Market
- 3.3.4 Italian POC Diagnostic Market
- 3.3.5 Spanish POC Diagnostic Market
3.4 Japanese Women's Care Testing Market
3.5 Chinese Women's Care Market
3.6 Rest of the World Women's Care Testing Market
3.7 Women's Health Testing Individual Markets
- 3.7.1 Pregnancy Testing
- 3.7.2 Osteoporosis Testing
  - 3.7.2.1 In Vitro Blood Tests
  - 3.7.2.2 Bone Densitometry Devices
- 3.7.3 Prenatal Screening Testing
- 3.7.4 Fertility Testing
- 3.7.5 Drugs of Abuse Screening
  - 3.7.5.1 Acetaminophen
  - 3.7.5.2 Tricyclic Antidepressants
  - 3.7.5.3 Other Toxic Drugs
  - 3.7.5.4 Drug Testing Selectivity
  - 3.7.5.5 Methaqualone and Phencyclidine (PCP)
  - 3.7.5.6 Tetrahydrocannabinol (THC)
  - 3.7.5.7 Drug Panels by Toxidromes
- 3.7.6 Urine Strip Testing
- 3.7.7 Cancer Testing
  - 3.7.7.1 Breast Cancer
  - 3.7.7.2 CA
  - 3.7.7.3 CA
  - 3.7.7.4 BRCA1 Breast and Ovarian Cancer Gene
  - 3.7.7.5 HER-2
  - 3.7.7.6 HER-2 and Herceptin
  - 3.7.7.7 p53
  - 3.7.7.8 NMP66
  - 3.7.7.9 Mammastatin
  - 3.7.7.10 Ovarian Cancer
  - 3.7.7.11 Steroid Hormone Receptors
  - 3.7.7.11.1 Epidermal Growth Factor Receptor (EGF-R)
  - 3.7.7.12 Cervical Cancer
- 3.7.8 Human Papillomavirus (HPV) Testing
- 3.7.9 Hemoglobin Testing
- 3.7.10 Miscellaneous Testing
  - 3.7.10.1 Estriol
  - 3.7.10.2 Fetal Fibronectin
  - 3.7.10.3 Vaginal pH and Vaginitis
- 3.7.11 HIV
- 3.7.12 Pap Smears
- 3.7.13 Infectious Disease Testing
  - 3.7.13.1 Strep Testing
  - 3.7.13.2 Chlamydia
  - 3.7.13.3 Mononucleosis
  - 3.7.13.4 Rubella
  - 3.7.13.5 Staphylococcus Aurea
  - 3.7.13.6 Hepatitis
  - 3.7.13.7 Gonorrhea
  - 3.7.13.8 Urinary Tract Infections
- 3.7.14 Infant Jaundice
- 3.7.15 Prenatal Genetic Testing
4.0 World Mammography Market
4.1 Market Overview
- 4.1.1 Mammography
- 4.1.2 Digital Mammography
5.0 World Mammography Market
5.1 Market Overview
- 5.1.1 Introduction
- 5.1.2 World Mammography Markets Revenue
- 5.1.3 Mammography Markets by Region
- 5.1.4 Total Market Share
- 5.1.5 Competitive Structure
5.2 Market Opportunities
- 5.2.1 Resource Management for Mammography Markets
- 5.2.2 Movement to Higher Reimbursement Rates
- 5.2.3 Market Benchmarks for Increased Mammography Utilization
5.4 Strategic Outlook
- 5.4.1 Competitive Elements of Mammography Markets
- 5.4.2 Higher Reimbursement Rates
- 5.4.3 Volume Requirements
- 5.4.4 Product Innovation
- 5.4.5 Product Leadership
- 5.4.6 Product Line Strategy
- 5.4.7 Pricing Strategy & Reimbursement
- 5.4.8 Strategic Partnerships
5.5 Film-Based Mammography Market
- 5.5.1 Market Overview
- 5.5.2 Market Drivers
- 5.5.3 Market Restraints
- 5.5.4 Film-Based Mammography Market and Technology Trends
- 5.5.5 U.S. Market for Film-Based Screening Systems
- 5.5.6 Unit Shipment and Revenue Forecasts
6.0 Competitive Analysis
6.1 U.S. Installed Base Analysis
6.2 European Market for Film-Based Mammography Systems
- 6.2.1 Unit Shipment and Revenue Forecasts
7.0 Competitive Analysis
7.1 Installed Base Analysis
7.2 Japanese (Pacific Rim) Market for Analog Screening Systems
8.0 Competitive Analysis
8.1 Installed Base Analysis
9.0 Rest of the World Market for Analog Screening Systems
9.1 Unit Shipment and Revenue Forecasts
9.2 Installed Base Analysis
10.0 Digital X-Ray Mammography Market
10.1 Market Overview
10.2 Product Background
10.3 Product Description
11.0 Market Drivers
12.0 Market Restraints
13.0 Unit Shipment and Revenue Forecasts
14.0 Percentage Breakdown of Revenues by Region
14.1 Market Share
15.0 U.S. Market for Digital Mammography Systems
15.1 U.S. Sales
15.2 Competitive Analysis
16.0 European Market for Digital Mammography Systems
16.1 Unit Shipment and Revenue Forecasts
16.2 Competitive Analysis
16.3 Installed Base Analysis
17.0 Japanese (Pacific Rim) Market for Digital Mammography Systems
17.1 Unit Shipment and Revenue Forecasts
17.2 Competitive Analysis
17.3 Installed Base Analysis
18.0 Women's Health Testing: Growth Regulators
18.1 Moderators of Growth
18.2 Personnel Acceptance
18.3 Key People for Women's Health Testing
18.4 Key Elements for Women's Health Testing
18.5 Women's Health Testing and Reimbursement
18.6 Rapid Near Patient Testing in Hospitals
18.7 Satellite Facilities
18.8 Regionalization of Laboratory Care
18.9 Requirements for Women's Health Testing
18.10 Clinical Laboratory Improvement Act of 1988 (CLIA)
19.0 Business Trends in the Industry
19.1 Sector Consolidation
19.2 Diagnostic Testing Growth Trends
19.3 Acquisition, License Agreements, Internal Development, Partnerships
19.4 Product Testing Depth in Women's Health Testing
19.5 Government Regulation
- 19.5.1 U.S. Regulation
  - 19.5.1.1 Importing Medical Devices into the U.S
  - 19.5.1.2 Exporting Medical Devices from the U.S
- 19.5.2 U.K. Regulation
- 19.5.3 E.U. Regulation
- 19.5.4 Japanese Regulation
19.6 Increased Market Penetration
19.7 Legal Issues
20.0 Important Technology Trends
21.0 Company Profiles
21.1 TriPath Imaging
21.2 LifeScan Corporation
21.3 OraSure
21.4 Bayer Corporation
21.5 Abbott Diagnostics
21.6 Cytyc Corporation
21.7 Inverness Medical Innovations
21.8 Johnson & Johnson
21.9 Quidel
21.10 Biomerica
21.11 Genzyme Diagnostics
21.12 Adeza Biomedical Corporation
21.13 Jiangnan Biotech
21.14 DiaDexus LLC
21.15 Digene
21.16 Matritech
21.17 General Electric Medical Systems
21.18 Dalsa
21.19 Icad, Inc
21.20 Imaging Diagnostic Systems Inc
21.21 FujiFilm Medical Systems
21.22 Fischer Imaging
21.23 Instrumentarium Imaging, Inc
21.24 Hologic Inc
21.25 Agfa-Gevaert Corporation
21.26 Sectra Imtec AB
21.27 R2 Technology, Inc
21.28 Rad-Icon Imaging Corp
21.29 Kodak Health Imaging Division
21.30 Siemens Medical Solutions
21.31 CADx Medical Systems
21.32 Vidar Systems Corp
21.33 CMT Medical Systems
21.34 DBA Systems
21.35 Scanis Inc
21.36 SmartLight
21.37 Diagnostic Imaging Systems
21.38 Roche Diagnostics
21.39 Myraid Genetics
21.40 Shanghai SIIC Kehua Biotech Co., Ltd. (Kehua Biotech)
21.41 LifePoint, Inc
21.41 Avitar Inc
21.42 Cozart Biosciences
21.43 Enterix, Inc
21.44 Kyowa Medex Co., Ltd
21.45 Iatron
21.46 Denka Seiken Co., Ltd
21.47 Accurex Biomedical, Pvt., Ltd
21.48 Ambri Ltd
21.49 Thermo Biostar
21.50 Axis-Shield
21.51 Polymedco
21.52 Medix Biochemica
21.53 Pheromone Sciences
21.54 Ostex International, Inc
21.55 Procrea
21.56 American Biomedica Corp
22.0 Appendices
22.1 Digital Database for Screening Mammography (DDSM)
22.2 Sources of National Cancer Institute Information
22.3 Screening Mammograms: Questions and Answers
22.4 FDA Rule: State Certification of Mammography Facilities

INDEX OF TABLES 

Table 1: Worldwide Market Share In Vitro Diagnostic Companies
Table 2: Worldwide In Vitro Diagnostics Market Size 2001-2007
Table 3: Worldwide In Vitro Central Laboratory Diagnostic Testing 2001-2007
Table 4: Worldwide Near Patient Diagnostic Testing 2001-2007
Table 5: Top Drugstore Retailers in the U.S
Table 6: Top Drugstore Wholesalers in the U.S
Table 7: U.S. Women's Health Diagnostics Products Market Sales 1992-2008
Table 8: U.S. Clinical Diagnostic Women's Test Market Segments 2002
Table 9: Self-Perceived Health Status for European Women 65-74 Years
Table 10: Percentage with Disability Due to Long-Standing Illness for European Women 65+ Years
Table 11: Regional Comparison Healthcare and IVD
Table 12: European Women's Care Testing Market
Table 13: European Women's Care Testing Diagnostics Market
Table 14: German Women's Care Testing Diagnostics Products Market Sales
Table 15: The German Patient Care Laboratory Test Market
Table 16: The German Alternate Site Testing Market
Table 17: The German Hospital Point of Care Market
Table 18: German Clinical Diagnostic Test Market Segments 2002, Revenue from Clinical Laboratory Testing
Table 19: German Clinical Diagnostic Rapid Women's Test Market Segments 2002
Table 20: The U.K. IVD Market
Table 21: U.K. Women's Health Diagnostics Products Market Sales
Table 22: Major U.K. IVD Manufacturers
Table 23: U.S. IVD Manufacturers Doing Business in the U.K
Table 24: Other European Companies that Manufacture IVD Products in the United Kingdom
Table 25: French Women's Health Diagnostics Products Market Sales
Table 26: Italian Women's Health Diagnostics Products Market Sales
Table 27: Spanish Women's Heath Diagnostics Products Market Sales
Table 28: Japan Women's Care Testing Market
Table 29: Chinese Women's Care Diagnostics Products Market Sales
Table 30: The ROW Women's Care Testing Market
Table 31: U.S. Women's Health Testing Pregnancy Testing Market
Table 32: U.S. Market Share for Rapid Women's Health Testing Pregnancy Tests
Table 33: The Pregnancy Test Market for OTC Testing in the U.S
Table 34: Home Pregnancy Tests Available in the U.S. Market
Table 35: Osteoporosis Risk Factors that Cannot Be Changed
Table 36: Osteoporosis Risk Factors that Can Be Changed
Table 37: Prenatal Screening Types
Table 38: History: Parental Genetic Traits
Table 39: Female Factor Infertility
Table 40: Frequency of Mutation Based Upon Ethnicity
Table 41: CF Carrier Risk by Ethnic Group
Table 42: Reasons for CF Testing
Table 43: CF Testing Methodology
Table 44: CF Gene Detection Rates Vary by Ethnic Background
Table 45: Global Market for CF Diagnostic Testing
Table 46: U.S. Market for CF Diagnostic Testing
Table 47: Commercial CF Screening Products
Table 48: Emerging CF Screening Products
Table 49: CF Screening Technology Summary
Table 50: Future Trends in Prenatal Genetic Testing
Table 51: The Fertility Testing Market in the U.S
Table 52: Ovulation Predictors
Table 53: U.S. Point of Care Drugs of Abuse Testing Market
Table 54: Global Urine Strip Market
Table 55: The Glucose Market for OTC Testing in the U.S
Table 56: TPA Marker Sensitivity
Table 57: Facts about HPV Risk Factors
Table 58: Relationship Between HPV and Cervical Carcinoma
Table 59: HPV and Cervical Carcinoma Risk
Table 60: Rationale for Reflex HPV Testing with Cytology
Table 61: Rationale Against Reflex HPV Testing with Cytology
Table 62: Predictability of HPV Test by Abnormal Pap Smear Type
Table 63: Incidence of Cervical Cancer and Cytological Abnormalities
Table 64: Long Term Trends in HPV Testing
Table 65: U.S. Women's Health Testing Market for HIV
Table 66: Countries with the Highest Prevalence of HIV / AIDS
Table 67: Births of HIV Infected Babies in U.S. 1991-2000
Table 68: U.S. Strep Testing Market Size
Table 69: U.S. Market for Rapid Point of Care StrepTests
Table 70: The U.S. Chlamydia Testing Market
Table 71: Summary of Hepatitis Test Technology
Table 72: Genetic Screening During Pregnancy
Table 73: Ultrasound Screening
Table 74: U.S. Healthcare Expenditures
Table 75: Spending on Health by Country
Table 76: U.S. Use of Mammography in Women Over 40
Table 77: Annual Mammography Procedures in the U.S
Table 78: Annual Mammography Procedures in Europe
Table 79: Annual Mammography Procedures in Japan
Table 80: Annual Mammography Procedures in the Rest of the World
Table 81: U.S. Mammography Facts
Table 82: Breast Cancer Survival Rates by Country
Table 83: Surgical Biopsies Performed in the U.S
Table 84: Benefits of Digital Mammography
Table 85: The Worldwide Mammography Instrument Market
Table 86: Worldwide Mammography Instrumentation Placements
Table 87: Worldwide Film-Based Mammography Instrumentation Placements
Table 88: Worldwide Mammography Film-Based Instrument Market
Table 89: Worldwide Mammography Film-Based Instrument Market by Region
Table 90: U.S. Mammography Film-Based Instrument Market
Table 91: U.S. Mammography Film-Based Instrument Market Manufacturer Share
Table 92: U.S. Film-Based Mammography Instrumentation Placements
Table 93: European Mammography Film-Based Instrument Market
Table 94: European Film-Based Mammography Instrumentation Placements
Table 95: European Mammography Film-Based Instrument Market Manufacturer Share
Table 96: Japanese Mammography Film-Based Instrument Market
Table 97: Japanese Film-Based Mammography Instrumentation Placements
Table 98: Japanese Mammography Film-Based Instrument Market Manufacturer Share
Table 99: ROW Mammography Film-Based Instrument Market
Table 100: ROW Film-Based Mammography Instrumentation Placements
Table 101: Advantages of Digital Mammography
Table 102: Worldwide Digital General Radiography Market
Table 103: Worldwide Market for Digital Mammography Systems Annual Unit Sales
Table 104: Worldwide Market for Digital Mammography Systems
Table 105: Worldwide Mammography Digital Instrumentation Placements
Table 106: Worldwide Mammography Digital Instrument Market by Region
Table 107: Share of Worldwide Market for Digital Mammography Systems by Competitor
Table 108: U.S. Mammography Digital Instrument Market
Table 109: U.S. Digital Mammography Instrumentation Placements
Table 110: European Mammography Digital Instrument Market
Table 111: European Digital Mammography Instrumentation Placements
Table 112: Japanese Mammography Digital Instrument Market
Table 113: Japanese Digital Mammography Instrumentation Placements
Table 114: Products Marketed By Abbott in the Diagnostic Market

Women's Health

Women’s Health Diagnostic Tests

Price £670.00

Summary

Content

Bookmark this Product